Patient Controlled Injectors Market Insights, Growth, Share, Size, Demand: 2024-2033

"The new report published by The Business Research Company, titled ""Patient Controlled Injectors Global Market Report 2024 - Market Size, Trends, And Global Forecast 2024-2033"", delivers an in-depth analysis of the leading size and forecasts, investment opportunities, winning strategies, market drivers and trends, competitive landscape, and evolving market trends.

As per the report, the patient-controlled injectors market size has grown rapidly in recent years. It will grow from $4.01 billion in 2023 to $4.51 billion in 2024 at a compound annual growth rate (CAGR) of 12.5%. The patient-controlled injectors market size is expected to see rapid growth in the next few years. It will grow to $7.32 billion in 2028 at a compound annual growth rate (CAGR) of 12.8%.

Download Free Sample Report @ https://www.thebusinessresearchcompany.com/sample.aspx?id=16759&type=smp

Growth Of The Patient-Controlled Injectors Market Driven By Rising Prevalence Of Chronic Diseases
The increase in the prevalence of chronic diseases is expected to propel the growth of the patient-controlled injectors market going forward. Chronic illness is a long-term health condition that usually lasts three months or longer and may worsen over time. The rise in chronic illness is due to factors such as the aging population, the obesity epidemic, socioeconomic factors, and environmental exposures. Chronic diseases use patient-controlled injectors to allow patients to self-administer medications with precision, ease, and on a schedule that aligns with their treatment plans. For instance, in January 2023, according to the National Center for Biotechnology Information (NCBI), a US-based medicine library, the number of people aged 50 and above who suffer from one or more chronic illnesses is expected to increase by 99.5% by 2050, from 71.52 million in 2020 to 142.66 million. Therefore, the increase in the prevalence of chronic diseases is expected to drive the growth of the patient-controlled injectors market.

Major Companies Innovate In Patient Controlled Injectors Market With New Autoinjector Platforms
Major companies operating in the patient-controlled injectors market are developing innovative products, such as ready-to-use syringes, to serve customers with advanced features better. Ready-to-use syringes are prefilled, sterilized syringes with a predetermined dose of medication, eliminating the need for manual preparation and reducing the risk of contamination and dosing errors. For instance, in October 2022, Ypsomed AG, a Switzerland-based medical equipment manufacturer, launched a new autoinjector platform designed for liquid pharmaceuticals with capacities ranging from 1.5 to 5.5 ml. This innovative device features an ergonomic design for ease of use, ensuring patient comfort during injections. It includes advanced safety mechanisms to prevent accidental needle sticks and provides visual and audible feedback to confirm the successful delivery of the medication. The autoinjector is also compatible with various viscosities, making it versatile for therapeutic applications.

The patient controlled injectors market covered in this report is segmented -

1) By Product: Electronic Wearable Injector, Mechanical Wearable Injector, Infusion Pumps
2) By Application: Cancer Treatment, Auto-Immune Treatment, Blood Disorder Treatment, Other Application
3) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Mail Order Pharmacies

Buy Now & Get Exclusive Discount on this Report, Checkout link @
https://www.thebusinessresearchcompany.com/Discount?id=16759&type=discount

Major companies operating in the patient controlled injectors market are Medtronic plc, Becton Dickinson and Company, West Pharmaceutical Services, SCHOTT AG, Gerresheimer AG, Phillips-Medisize, Vetter Pharma-Fertigung GmbH & Co. KG, Stevanato Group, Ypsomed AG, Nemera, B. Braun Melsungen AG, Elcam Medical, Owen Mumford, Bespak, Unilife Corporation, Crossject, SHL Group, AptarGroup Inc., Credence MedSystems, Weibel CDS AG, Sorrel Medical

Contents of the report:
1. Executive Summary
2. Patient Controlled Injectors Market Report Structure
3. Patient Controlled Injectors Market Trends And Strategies
4. Patient Controlled Injectors Market - Macro Economic Scenario
5. Patient Controlled Injectors Market Size And Growth
…..
27. Patient Controlled Injectors Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix

Explore the report store to make a direct purchase of the report @ https://www.thebusinessresearchcompany.com/report/patient-controlled-injectors-global-market-report

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

"Learn More About The Business Research Company

The Business Research Company (www.thebusinessresearchcompany.com) is a leading market intelligence firm renowned for its expertise in company, market, and consumer research. With a global presence, TBRC's consultants specialize in diverse industries such as manufacturing, healthcare, financial services, chemicals, and technology, providing unparalleled insights and strategic guidance to clients worldwide."

This release was published on openPR.